期刊
SEMINARS IN THROMBOSIS AND HEMOSTASIS
卷 35, 期 6, 页码 554-559出版社
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-0029-1241048
关键词
Atrial fibrillation; oral anticoagulation; stroke prevention
Atrial fibrillation (AF) is the most common sustained arrhythmia of the Western world. The increased ischemic stroke risk of the AF patient is one of the most important clinical issues to manage. Despite the well-known benefit of oral anticoagulation in high-risk AF patients, these drugs are widely underused in daily practice all over the world. We describe old and new paradigms of the use of oral anti coagulation. In the future, increased comprehensibility of stroke risk scores, development of a validated clinical bleed risk score, and new patient and physician user-friendly antithrombotic medication may contribute to improved adequate use of oral anticoagulation in AF patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据